Penumbra, Inc. (PEN)

NYSE: PEN · USD

$318

-5.70 (-1.8%)· Recorded snapshot

Market cap	12.5B
Revenue (ttm)	1.5B
Net income (ttm)	160.6M
EPS (ttm)	$4.07
Shares out	39.4M
P/E (trailing)	78.3x
P/E (forward)	57.1x
Volume	809,617
Beta	0.70

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.5B
Net income (ttm): 160.6M
EPS (ttm): $4.07
P/E (trailing): 78.3x
P/E (forward): 57.1x
Market cap: 12.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Manter

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E57.1

P25 n/aP50 n/aP75 n/a

Trailing P/E78.3

P25 n/aP50 n/aP75 n/a

ROE11.4

P25 n/aP50 n/aP75 n/a

ROIC13.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PEN indicators

Market & fundamental data

Available fields

267

Groups with data

Currency

USD

Showing 267 of 267 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001321732
Company name	Penumbra, Inc.
Country	United States
Country code	US
CUSIP number	70975L107
Earnings date	2026-11-09
Earnings time	amc
Employees	4,700
Employees change	200
Employees growth	4.44%
Enterprise value	$12.1B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2004
Industry	Medical Devices
IPO date	2015-09-18
Is primary listing	Yes
Is SPAC	No
ISIN number	US70975L1070
Last 10-K release date	2026-02-25
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$12.5B
Market cap category	Large-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$318.35
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	PEN
U.S. state	California
Website	https://www.penumbrainc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	76.33x
Average P/E ratio (10Y)	397.74x
Average P/E ratio (3Y)	198.32x
Average P/E ratio (5Y)	424.7x
Earnings yield	1.28%
EV/Earnings	75.37x
EV/EBIT	64.6x
EV/EBITDA	59.25x
EV/FCF	56.06x
EV/Sales	8.04x
FCF / EV yield	1.78%
FCF yield	1.72%
Forward EV/Sales	7.14x
Forward P/E	57.12x
Forward P/S	7.4x
Graham number	59.64006
Graham upside	-81.28%
Industry forward P/E	19.74x
Industry P/E	39.16x
Lynch fair value	$101.70
Lynch upside	-68.08%
P/(FCF - SBC) ratio	80.23x
P/(OCF - SBC) ratio	57.48x
P/B ratio	8.34x
P/E ratio	78.26x
P/FCF ratio	58.12x
P/OCF ratio	45.17x
P/S ratio	8.34x
PEG ratio	1.66x
Price / tangible book value	9.24x
Price/EBITDA ratio	61.43x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	12.45%
EBITDA margin	13.57%
Effective tax rate	21.22%
FCF margin	14.35%
Gross margin	67.84%
Operating margin	12.45%
Pretax margin	13.54%
Profit margin	10.67%
Profit per employee	$34,168
Profitable quarters	8
Profitable years	3
Revenue per employee	$320,186
ROA	6.42%
ROA (5Y)	3.13%
ROCE	10.76%
ROE	11.37%
ROE (5Y)	4.69%
ROIC	13.67%
ROIC (5Y)	5.96%
SBC / revenue	3.95%
Tax / revenue	2.87%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	8.81%
EPS growth (Q)	-23.48%
EPS growth (QoQ)	7.32%
EPS growth 10Y	33.31%
EPS growth 3Y	74.97%
EPS growth 5Y	56.78%
EPS growth years	1
FCF growth	33.59%
FCF growth (Q)	10.81%
FCF growth (QoQ)	-55.6%
FCF growth 3Y	650.87%
Gross profit growth	19.98%
Gross profit growth (Q)	18.27%
Gross profit growth 3Y	19.94%
Gross profit growth 5Y	18.68%
Net income growth	8.72%
Net income growth (Q)	-23.1%
Net income growth (QoQ)	6.83%
Net income growth 3Y	76.66%
Net income growth 5Y	58.8%
Net income growth years	1
OCF growth	37.87%
OCF growth (Q)	2.53%
OCF growth (QoQ)	-47.01%
OCF growth 3Y	146.02%
Operating income growth	17.62%
Operating income growth (Q)	0.52%
Operating income growth 3Y	73.03%
Revenue growth	17.55%
Revenue growth (Q)	14.9%
Revenue growth (QoQ)	4.08%
Revenue growth 10Y	20.78%
Revenue growth 3Y	17.08%
Revenue growth 5Y	17.52%
Revenue growth quarters	24
Revenue growth years	12

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-61.9M
Depreciation and amortization	$16.9M
EBIT	$187.3M
EBITDA	$204.3M
EPS	$4.07
FCF per share	$5.48
Financing cash flow	$16.1M
Free cash flow	$215.9M
Free cash flow minus SBC	$156.4M
Gross profit	$1B
Income taxes	$43.2M
Investing cash flow	$-510.2M
Net borrowing	$-2.4M
Net cash flow	$-216.5M
Net income	$160.6M
Operating cash flow minus SBC	$218.3M
Operating income	$187.3M
Revenue	$1.5B
Stock-based compensation	$59.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	17.68
Book value per share	$38.86
Debt / EBITDA	0.89
Debt / equity	0.14
Debt / FCF	0.99
Goodwill	$166.5M
Interest coverage	144.22
Long-term assets	$630.6M
Long-term liabilities	$210.2M
Net cash (debt)	$446.1M
Net cash / market cap	3.55%
Net cash growth	118.63%
Net debt / EBITDA	-2.18
Net debt / equity	-0.29
Net debt / FCF	-2.07
Piotroski F-Score	6
Property, plant and equipment	$338.3M
Shareholders' equity	$1.5B
Tangible book value	$1.4B
Tangible book value per share	$34.49
Total assets	$2B
Total cash	$658.8M
Total debt	$212.7M
Total liabilities	$444M
WACC	7.98%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.82
Current assets	$1.3B
Current liabilities	$233.8M
Current ratio	5.75
Inventory turnover	1.11
Net working capital	$468.3M
Quick ratio	3.63
Working capital	$1.1B
Working capital turnover	1.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.07%
Dividend yield	0%
Shareholder yield	0.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	394.26%
10Y return CAGR	17.33%
10Y total return	394.26%
150-day SMA	$322.40
1D price change	-1.76%
1M price change	0.13%
1M total return	0.13%
1W price change	-1.56%
1W total return	-1.56%
1Y price change	28.75%
1Y return CAGR	28.77%
1Y total return	28.75%
20-day SMA	$320.72
200-day SMA	$327.36
3M price change	-0.06%
3M total return	-0.06%
3Y price change	65.6%
3Y return CAGR	18.31%
3Y total return	65.6%
50-day SMA	$320.72
50-day SMA vs 200-day SMA	50under200
52-week high	$362.41
52-week high date	2026-01-21
52-week low	$221.26
52-week low date	2025-11-03
5Y price change	17.64%
5Y return CAGR	3.3%
5Y total return	17.64%
6M price change	-2.65%
6M total return	-2.65%
All-time high	$362.41
All-time high date	2026-01-21
All-time low	$35.32
All-time low date	2015-10-22
Average true range (ATR)	$2.26
Average volume	365.4K
Beta (1Y)	-0.26
Beta (2Y)	-0.01
Beta (5Y)	0.7
Change from 52-week high	-12.16%
Change from 52-week low	43.88%
Change from all-time high	-11.9%
Change from all-time low	804.12%
Change from open	-0.37%
Day's gap	-1.39%
Dollar volume	$257.7M
High price	$319.93
Low price	$316.69
Monthly RSI	57.32
Open price	$319.52
Position in 52-week range	51.23%
Premarket change	-1.52%
Premarket close	$324.04
Premarket price	$319.11
Premarket volume	1.4K
Previous close	$324.04
Price vs 150-day SMA	-0.96%
Price vs 20-day SMA	-0.44%
Price vs 200-day SMA	-2.47%
Price vs 50-day SMA	-0.44%
Relative volume	2.22
RSI	43.71
Sharpe ratio	0.91
Sharpe ratio (3Y)	0.47
Sharpe ratio (5Y)	0.18
Sortino ratio	2.34
Sortino ratio (3Y)	0.97
Sortino ratio (5Y)	0.43
Volume	809.6K
Weekly RSI	48.75
YTD price change	2.7%
YTD total return	2.7%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38.3M
Float percentage	97.17%
Shares change (QoQ)	0.07%
Shares change (YoY)	-0.07%
Shares held by insiders	2.76%
Shares held by institutions	88.11%
Shares outstanding	39.4M
Short % of float	5.87%
Short % of shares	5.7%
Short ratio	6 days

Deeper analysis on PEN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PEN report

Is a complete PEN research report available?

No complete published report is available for Penumbra, Inc. (PEN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Penumbra, Inc. (PEN)

Price

Financial snapshot

Fair-value bridge

Latest news · PEN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PEN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PEN

Frequently asked questions